A 2-step phase I study evaluating the safety of (neo-)adjuvant cisplatin-pemetrexed and stereotactic radiotherapy (SRT) for patients with stage IB non-small-cell lung cancer (NSCLC).

Trial Profile

A 2-step phase I study evaluating the safety of (neo-)adjuvant cisplatin-pemetrexed and stereotactic radiotherapy (SRT) for patients with stage IB non-small-cell lung cancer (NSCLC).

Recruiting
Phase of Trial: Phase I

Latest Information Update: 29 Apr 2014

At a glance

  • Drugs Pemetrexed (Primary) ; Cisplatin
  • Indications Non-small cell lung cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 16 Jun 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top